This suggestion is supported by the fact that genetic ablation of BMPRII gene restricted to the pulmonary endothelium clearly leads to the development of PAH, which implicates the endothelium as a critical target in the molecular pathogenesis of the proliferative vasculopathy in PAH pathogenesis [27]. The gene discussed is BMPR2; the disease is vascular disorder.